Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma

A multicenter trial

Donald L. Morton, John F. Thompson, Richard Essner, Robert Elashoff, Stacey L. Stern, Omgo E. Nieweg, Daniel F. Roses, Constantine P. Karakousis, Nicola Mozzillo, Douglas Reintgen, He Jing Wang, Edwin C. Glass, Alistair J. Cochran

Research output: Contribution to journalArticle

643 Citations (Scopus)

Abstract

Objective: To evaluate the multicenter application of intraoperative lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection (LM/SL/SCLND) for the management of early-stage melanoma. Summary Background Data: The multidisciplinary technique of LM/SL/SCLND has been widely adopted, but not validated in a multicenter trial. The authors began the international Multicenter Selective Lymphadenectomy Trial (MSLT) 5 years ago to evaluate the survival of patients with early-stage primary melanoma after wide excision alone versus wide excision plus LM/SL/SCLND. This study examined the accuracy of LM/SL/SCLND in the MSLT, using the experience of the organizing center (John Wayne Cancer Institute [JWCI]) as a standard for comparison. Methods: Before entering patients into the randomization phase, each center in the MSLT was required to finish a 30-case learning phase with complete nuclear medicine, pathology, and surgical review. Selection of MSLT patients in the LM/SL/SCLND treatment arm was based on complete pathologic and surgical data. The comparison group of JWCI patients was selected using these criteria: primary cutaneous melanoma having a thickness ≥1 mm with a Clark level ≥III, or a thickness

Original languageEnglish
Pages (from-to)453-465
Number of pages13
JournalAnnals of Surgery
Volume230
Issue number4
DOIs
Publication statusPublished - Oct 1999

Fingerprint

Lymph Node Excision
Multicenter Studies
Melanoma
cyhalothrin
Surgical Pathology
Nuclear Medicine
Random Allocation
Neoplasms
Learning

ASJC Scopus subject areas

  • Surgery

Cite this

Morton, D. L., Thompson, J. F., Essner, R., Elashoff, R., Stern, S. L., Nieweg, O. E., ... Cochran, A. J. (1999). Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Annals of Surgery, 230(4), 453-465. https://doi.org/10.1097/00000658-199910000-00001

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma : A multicenter trial. / Morton, Donald L.; Thompson, John F.; Essner, Richard; Elashoff, Robert; Stern, Stacey L.; Nieweg, Omgo E.; Roses, Daniel F.; Karakousis, Constantine P.; Mozzillo, Nicola; Reintgen, Douglas; Wang, He Jing; Glass, Edwin C.; Cochran, Alistair J.

In: Annals of Surgery, Vol. 230, No. 4, 10.1999, p. 453-465.

Research output: Contribution to journalArticle

Morton, DL, Thompson, JF, Essner, R, Elashoff, R, Stern, SL, Nieweg, OE, Roses, DF, Karakousis, CP, Mozzillo, N, Reintgen, D, Wang, HJ, Glass, EC & Cochran, AJ 1999, 'Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial', Annals of Surgery, vol. 230, no. 4, pp. 453-465. https://doi.org/10.1097/00000658-199910000-00001
Morton, Donald L. ; Thompson, John F. ; Essner, Richard ; Elashoff, Robert ; Stern, Stacey L. ; Nieweg, Omgo E. ; Roses, Daniel F. ; Karakousis, Constantine P. ; Mozzillo, Nicola ; Reintgen, Douglas ; Wang, He Jing ; Glass, Edwin C. ; Cochran, Alistair J. / Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma : A multicenter trial. In: Annals of Surgery. 1999 ; Vol. 230, No. 4. pp. 453-465.
@article{b5c871a065db4b1db7c769f8f2a8a501,
title = "Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial",
abstract = "Objective: To evaluate the multicenter application of intraoperative lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection (LM/SL/SCLND) for the management of early-stage melanoma. Summary Background Data: The multidisciplinary technique of LM/SL/SCLND has been widely adopted, but not validated in a multicenter trial. The authors began the international Multicenter Selective Lymphadenectomy Trial (MSLT) 5 years ago to evaluate the survival of patients with early-stage primary melanoma after wide excision alone versus wide excision plus LM/SL/SCLND. This study examined the accuracy of LM/SL/SCLND in the MSLT, using the experience of the organizing center (John Wayne Cancer Institute [JWCI]) as a standard for comparison. Methods: Before entering patients into the randomization phase, each center in the MSLT was required to finish a 30-case learning phase with complete nuclear medicine, pathology, and surgical review. Selection of MSLT patients in the LM/SL/SCLND treatment arm was based on complete pathologic and surgical data. The comparison group of JWCI patients was selected using these criteria: primary cutaneous melanoma having a thickness ≥1 mm with a Clark level ≥III, or a thickness",
author = "Morton, {Donald L.} and Thompson, {John F.} and Richard Essner and Robert Elashoff and Stern, {Stacey L.} and Nieweg, {Omgo E.} and Roses, {Daniel F.} and Karakousis, {Constantine P.} and Nicola Mozzillo and Douglas Reintgen and Wang, {He Jing} and Glass, {Edwin C.} and Cochran, {Alistair J.}",
year = "1999",
month = "10",
doi = "10.1097/00000658-199910000-00001",
language = "English",
volume = "230",
pages = "453--465",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma

T2 - A multicenter trial

AU - Morton, Donald L.

AU - Thompson, John F.

AU - Essner, Richard

AU - Elashoff, Robert

AU - Stern, Stacey L.

AU - Nieweg, Omgo E.

AU - Roses, Daniel F.

AU - Karakousis, Constantine P.

AU - Mozzillo, Nicola

AU - Reintgen, Douglas

AU - Wang, He Jing

AU - Glass, Edwin C.

AU - Cochran, Alistair J.

PY - 1999/10

Y1 - 1999/10

N2 - Objective: To evaluate the multicenter application of intraoperative lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection (LM/SL/SCLND) for the management of early-stage melanoma. Summary Background Data: The multidisciplinary technique of LM/SL/SCLND has been widely adopted, but not validated in a multicenter trial. The authors began the international Multicenter Selective Lymphadenectomy Trial (MSLT) 5 years ago to evaluate the survival of patients with early-stage primary melanoma after wide excision alone versus wide excision plus LM/SL/SCLND. This study examined the accuracy of LM/SL/SCLND in the MSLT, using the experience of the organizing center (John Wayne Cancer Institute [JWCI]) as a standard for comparison. Methods: Before entering patients into the randomization phase, each center in the MSLT was required to finish a 30-case learning phase with complete nuclear medicine, pathology, and surgical review. Selection of MSLT patients in the LM/SL/SCLND treatment arm was based on complete pathologic and surgical data. The comparison group of JWCI patients was selected using these criteria: primary cutaneous melanoma having a thickness ≥1 mm with a Clark level ≥III, or a thickness

AB - Objective: To evaluate the multicenter application of intraoperative lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection (LM/SL/SCLND) for the management of early-stage melanoma. Summary Background Data: The multidisciplinary technique of LM/SL/SCLND has been widely adopted, but not validated in a multicenter trial. The authors began the international Multicenter Selective Lymphadenectomy Trial (MSLT) 5 years ago to evaluate the survival of patients with early-stage primary melanoma after wide excision alone versus wide excision plus LM/SL/SCLND. This study examined the accuracy of LM/SL/SCLND in the MSLT, using the experience of the organizing center (John Wayne Cancer Institute [JWCI]) as a standard for comparison. Methods: Before entering patients into the randomization phase, each center in the MSLT was required to finish a 30-case learning phase with complete nuclear medicine, pathology, and surgical review. Selection of MSLT patients in the LM/SL/SCLND treatment arm was based on complete pathologic and surgical data. The comparison group of JWCI patients was selected using these criteria: primary cutaneous melanoma having a thickness ≥1 mm with a Clark level ≥III, or a thickness

UR - http://www.scopus.com/inward/record.url?scp=0033497863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033497863&partnerID=8YFLogxK

U2 - 10.1097/00000658-199910000-00001

DO - 10.1097/00000658-199910000-00001

M3 - Article

VL - 230

SP - 453

EP - 465

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 4

ER -